Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388382 | PMC |
| http://dx.doi.org/10.1093/ijnp/pyad031 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy and safety of a selective partial agonist for nociception/orphanin-FQ peptide (NOP) receptors in patients with insomnia disorder.
Br J Clin Pharmacol
August 2025
Imbrium Therapeutics, Stamford, CT, USA.
Aims: Insomnia is a common sleep disorder, affecting up to 20% of the world population and adversely impacting productivity, health, and overall well-being. Although pharmacologic options exist to treat insomnia, the health-related quality of life for patients who are prescribed hypnotics is no higher than for those who are not, revealing a significant treatment gap. Sunobinop, an oral, selective, potent, partial agonist of the nociceptin receptor (NOP), was evaluated for efficacy and safety in the treatment of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) insomnia disorder.
View Article and Find Full Text PDFActivation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice.
Br J Pharmacol
August 2025
Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.
Background And Purpose: Migraine is a neurovascular disorder largely mediated by calcitonin gene-related peptide (CGRP). This study explores the role of the nociceptin/orphanin FQ (N/OFQ)-N/OFQ receptor (NOP) system in CGRP-induced periorbital mechanical allodynia (PMA) in mice.
Experimental Approach: Male or female wild type (NOP(+/+)) and NOP receptor knockout (NOP(-/-)) mice and CD-1 mice were used.
Ro 64-6198, a selective NOP receptor agonist attenuates social impairments associated with NTG-induced migraine pain.
Neuropsychopharmacology
August 2025
Department of Biopharmacy, Medical University of Lublin, Lublin, Poland.
Migraine is a debilitating neurological disorder with significant impact on quality of life, including social functioning. This study investigated the effects of nitroglycerin (NTG)-induced migraine in male and female mice on social behavior and neuronal activation and explored the therapeutic potential of nociceptin opioid peptide (NOP) receptor agonism. We found that acute NTG administration induced mechanical allodynia in periorbital region and paw as well as impaired social behavior in both sexes, albeit with sex-specific patterns.
View Article and Find Full Text PDFEffect of genetic deletion of nociceptin/orphanin FQ receptors on spatial and associative memory in rats.
Psychopharmacology (Berl)
July 2025
School of Pharmacy, Center for Neuroscience, Pharmacology Unit, University of Camerino, Via Madonna delle Carceri, 9, Camerino, 62032, Italy.
Rationale: A growing body of evidence suggests that the N/OFQ-NOP receptor system modulates learning and memory in rodents, with NOP receptor agonists impairing memory and antagonists reversing this effect. Moreover, previous studies on transgenic mice showed that genetic deletion of the NOP receptor enhances spatial and aversive memory.
Objectives: To further investigate the role of the NOP receptor system in learning and memory, we used a rat model to assess how genetic deletion of NOP receptors affects spatial and associative memory, comparing it with a wild-type (WT) control group.
Background: Nociceptin (N/OFQ) and its receptor OPRL1 play crucial roles in emotional processing, reward-related behaviors, learning, and neurotransmitter regulation, but their involvement in Alzheimer's disease (AD) pathology remains poorly understood. This study investigated possible relationships between prepronociceptin ( ) and expression and psychiatric symptoms in AD, utilizing Natural Language Processing (NLP) to assess Research Domain Criteria (RDoC) domains.
Methods: Post-mortem brain tissue from the dorsal anterior cingulate gyrus (BA32) was analyzed in 61 donors across different Braak and Braak (B&B) stages.